HK1012193A1 - Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives - Google Patents

Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives

Info

Publication number
HK1012193A1
HK1012193A1 HK98113683A HK98113683A HK1012193A1 HK 1012193 A1 HK1012193 A1 HK 1012193A1 HK 98113683 A HK98113683 A HK 98113683A HK 98113683 A HK98113683 A HK 98113683A HK 1012193 A1 HK1012193 A1 HK 1012193A1
Authority
HK
Hong Kong
Prior art keywords
derivatives
carbothio
carboxy
amide
beta
Prior art date
Application number
HK98113683A
Other languages
English (en)
Inventor
Keith Biggadike
Panayiotis Alexandro Procopiou
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9526651.6A external-priority patent/GB9526651D0/en
Priority claimed from GBGB9613121.4A external-priority patent/GB9613121D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of HK1012193A1 publication Critical patent/HK1012193A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK98113683A 1995-12-29 1998-12-16 Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives HK1012193A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9526651.6A GB9526651D0 (en) 1995-12-29 1995-12-29 Compounds
GBGB9613121.4A GB9613121D0 (en) 1996-06-21 1996-06-21 Compounds
PCT/GB1996/003140 WO1997024365A1 (en) 1995-12-29 1996-12-19 Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives

Publications (1)

Publication Number Publication Date
HK1012193A1 true HK1012193A1 (en) 1999-07-30

Family

ID=26308402

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98113683A HK1012193A1 (en) 1995-12-29 1998-12-16 Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives

Country Status (34)

Country Link
US (1) US6197761B1 (es)
EP (1) EP0876392B1 (es)
JP (1) JP2947944B2 (es)
KR (1) KR19990076859A (es)
CN (1) CN1133643C (es)
AP (1) AP9801274A0 (es)
AT (1) ATE194356T1 (es)
AU (1) AU721865B2 (es)
BG (1) BG102625A (es)
BR (1) BR9612309A (es)
CA (1) CA2241728A1 (es)
CZ (1) CZ207498A3 (es)
DE (1) DE69609199T2 (es)
DK (1) DK0876392T3 (es)
EA (1) EA001401B1 (es)
EE (1) EE9800227A (es)
ES (1) ES2150150T3 (es)
GR (1) GR3034564T3 (es)
HK (1) HK1012193A1 (es)
HU (1) HUP9903707A3 (es)
IL (1) IL124938A0 (es)
IS (1) IS4781A (es)
MX (1) MX9805181A (es)
NO (1) NO311022B1 (es)
NZ (1) NZ324373A (es)
OA (1) OA10701A (es)
PE (1) PE87598A1 (es)
PL (1) PL327629A1 (es)
PT (1) PT876392E (es)
SI (1) SI0876392T1 (es)
SK (1) SK89198A3 (es)
TR (1) TR199801247T2 (es)
TW (1) TW498072B (es)
WO (1) WO1997024365A1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2215310T3 (es) * 1997-06-30 2004-10-01 Glaxo Group Limited Procedimiento para identificar compuestos que tienen una actividad sistemica reducida.
GB9909229D0 (en) * 1999-04-23 1999-06-16 Glaxo Group Ltd Enantiomers of mercapto lactones and processes for their synthesis
GB0017988D0 (en) * 2000-07-21 2000-09-13 Glaxo Group Ltd Novel process
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
OA12394A (en) * 2000-08-05 2004-07-09 Glaxo Group Ltd 6.Alpha-,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl)oxyl-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fuoromethyl ester as an anti-inflammatory agent.
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6759398B2 (en) * 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6787532B2 (en) 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
EP2039700A2 (en) * 2001-04-30 2009-03-25 Glaxo Group Limited Novel anti-inflammatory androstane derivatives
ATE399174T1 (de) * 2001-06-12 2008-07-15 Glaxo Group Ltd Neue anti inflammatorische 17.alpha.- heterozyklische ester von 17.beta.-carbothioat androstan derivativen
WO2003018575A1 (en) * 2001-08-24 2003-03-06 Wyeth Holdings Corporation 5-substituted-3(2h)-furanones useful for inhibition of farnesyl-protein transferase
GB0125259D0 (en) 2001-10-20 2001-12-12 Glaxo Group Ltd Novel compounds
GB0127160D0 (en) * 2001-11-12 2002-01-02 Glaxo Group Ltd Novel compounds
WO2003042229A1 (en) * 2001-11-12 2003-05-22 Glaxo Group Limited Non-aromatic heterocyclic esters of furan-2-one-esters of 17.beta.-carboxyl or 17.beta.-carbothio glucocorticoids
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
CA2530680A1 (en) * 2003-04-04 2004-10-14 Alpharma Aps Process for the preparation of steroidal carbothioic acid derivatives and intermediates
EP1466920A1 (en) * 2003-04-04 2004-10-13 Alpharma APS Process for the preparation of steroidal 17 beta-carbothioates
PT103202B (pt) 2004-10-19 2011-01-27 Hovione Farmaciencia S A Processo para a esterificação de um ácido carbotiótico
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
TWI374147B (en) * 2006-01-27 2012-10-11 Sun Pharma Advance Res Company Ltd Novel 11β-hydroxyandrosta-4-ene-3-ones
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
CN103087137A (zh) * 2011-11-07 2013-05-08 天津金耀集团有限公司 一种21位为硫代烃基的糖皮质激素
WO2024125639A1 (zh) * 2022-12-16 2024-06-20 津药生物科技（天津）有限公司 新型糖皮质激素、其制备方法及用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4093721A (en) * 1974-08-30 1978-06-06 Glaxo Laboratories Limited Pharmaceutical compositions of 6α,9α-difluoro-androst-4-ene-17β-carboxylates and derivatives thereof
US4188385A (en) * 1978-04-05 1980-02-12 Syntex (U.S.A.) Inc. Thioetianic acid derivatives
SE8306370D0 (sv) * 1983-11-18 1983-11-18 Draco Ab Novel androstane-17beta-carboxylic acid esters, a process and intermediates for their preparation, compositions and method for the treatment of inflammatory conditions
IL78144A0 (en) * 1985-04-04 1986-07-31 Draco Ab Novel androstane-17beta-carboxylic acid esters
US5767113A (en) * 1995-05-10 1998-06-16 The Salk Institute For Biological Studies Compounds useful for concurrently activating glucocorticoid-induced response and reducing multidrug resistance

Also Published As

Publication number Publication date
GR3034564T3 (en) 2001-01-31
DE69609199D1 (de) 2000-08-10
BR9612309A (pt) 1999-07-13
HUP9903707A2 (hu) 2000-03-28
JP2947944B2 (ja) 1999-09-13
DK0876392T3 (da) 2000-11-06
ES2150150T3 (es) 2000-11-16
CZ207498A3 (cs) 1998-11-11
OA10701A (en) 2002-05-21
AU721865B2 (en) 2000-07-13
TR199801247T2 (xx) 1998-11-23
PL327629A1 (en) 1998-12-21
BG102625A (en) 1999-04-30
EP0876392B1 (en) 2000-07-05
TW498072B (en) 2002-08-11
US6197761B1 (en) 2001-03-06
MX9805181A (es) 1998-10-31
AP9801274A0 (en) 1998-06-30
SK89198A3 (en) 1999-03-12
NZ324373A (en) 1999-10-28
NO311022B1 (no) 2001-10-01
NO983004L (no) 1998-08-26
NO983004D0 (no) 1998-06-26
IL124938A0 (en) 1999-01-26
AU1140997A (en) 1997-07-28
PE87598A1 (es) 1999-01-15
EE9800227A (et) 1998-12-15
SI0876392T1 (en) 2000-12-31
EP0876392A1 (en) 1998-11-11
EA199800484A1 (ru) 1999-02-25
ATE194356T1 (de) 2000-07-15
DE69609199T2 (de) 2001-03-01
EA001401B1 (ru) 2001-02-26
CN1209135A (zh) 1999-02-24
CN1133643C (zh) 2004-01-07
KR19990076859A (ko) 1999-10-25
WO1997024365A1 (en) 1997-07-10
JPH11501675A (ja) 1999-02-09
PT876392E (pt) 2000-12-29
IS4781A (is) 1998-06-23
HUP9903707A3 (en) 2000-04-28
CA2241728A1 (en) 1997-07-10

Similar Documents

Publication Publication Date Title
GR3034564T3 (en) Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives
GB2319250B (en) Derivatives of 6,8-Difluoro-7-Hydroxycoumarin
HUP0000474A3 (en) Arylethenesulfonamide derivatives and drug composition containing the same
PH31455A (en) Acyl derivatives of azolone.
NZ329176A (en) 2,5-dioxo-imidazolidine derivatives and medicaments
NZ321576A (en) 6-imidazol-1-ylmethyl-2-oxo-quinoline derivatives and medicaments
PL323726A1 (en) Novel derivatives of dolastatin, their production and application
IL117807A0 (en) 1,3-dihydro-1-(phenylalkyl)-2h-imidazol-2-one derivatives their preparation and use
PL316706A1 (en) Substituted derivatives of imidazolydinodione-2,4, method of obtaining them and pharmaceutic preparation
PL324992A1 (en) Novel derivatives of 2,3-dioxotetrahydoquinoxaline
PL329121A1 (en) Substituted derivatives of 1,2,3,4-tetrahydronaphtalene
ZA969221B (en) Indolealkyl derivatives of benzodioxanmethylamine.
ZA956679B (en) Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis.
HUP9602196A2 (en) Sulfonyl- and sulfinyl-benzoyl-guanidine derivatives and pharmaceutical compositions thereof
HUP9903701A3 (en) Process for the preparation of 2-chlorothiazole derivatives, intermediates and preparation thereof
NZ305898A (en) Taxoid derivatives and medicaments
ZA961392B (en) Antimigraine 1, 2, 5-thiadiazole derivatives of indolylalkylpyridinyl and pyrimidinylpiperazines.
AU3467697A (en) 3'-oximino-2',3'-dideoxynucleosides and derivatives of the same
HUP9602977A3 (en) Arylpiperidine and arylpiperazine derivatives and drugs containing the same
PL325632A1 (en) Derivatives of pyrizin-2-one, their application and intermediate compounds for obtaining them
HUP9602774A2 (en) Benzoxazepine derivatives, pharmaceutical compositions containing them and intermediates
ZA965276B (en) Carboxamide derivatives
HUP9700609A3 (en) 1,25-dihydroxy-12,22,23-trisdehydro-cholecalciferol derivatives, pharmaceutical compositions containing the same and intermediates
PL315675A1 (en) Derivatives of 12, 13-epoxytholosine and method of obtaining them
IL120285A (en) Process for the preparation of 1,5-benzothiazepine derivatives, process for the preparation of the intermediate thereof and an intermediate thereof

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20041219